Wordt geladen...
First‐in‐human study of the cancer peptide vaccine TAS0313 in patients with advanced solid tumors
TAS0313, a novel cancer vaccine cocktail, was developed to overcome the disadvantages of previously developed short and long peptide vaccines; it comprises several long peptides targeting multiple cancer antigens. We evaluated TAS0313 monotherapy in Japanese patients with advanced solid tumors for w...
Bewaard in:
| Gepubliceerd in: | Cancer Sci |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8019195/ https://ncbi.nlm.nih.gov/pubmed/33615628 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14765 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|